Asthma's Impact on Society: The Social and Economic Burden (Lung Biology in Health and Disease, V. 138)
Book Details
PublisherCRC Press
ISBN / ASIN0824719425
ISBN-139780824719425
AvailabilityUsually ships in 24 hours
Sales Rank6,270,477
MarketplaceUnited States 🇺🇸
Description
One of the first comprehensive studies of the social and economic consequences of this chronic pulmonary illness, Asthma's Impact on Society assesses how communities, families, and individuals confront asthma and try to minimize its deleterious effects.
Written by over 25 highly esteemed experts, Asthma's Impact on Society
defines the consequences of asthma in a community context, such as allocation of resources
determines how insights gained from the social sciences can improve clinical care of asthmatics
reviews outcomes, aside from physiological measures, that should be included in assessment of the condition and its treatments
calculates the economic burden asthma may contribute to individuals, the health care system, and society in general
presents new methods of measuring the impact of asthma on adult and pediatric patients
examines the financial burden on business due to absenteeism, hospitalization, and health insurance coverage
explains the basic principles of pharmacoeconomics as applied to asthma
and more!
Representing a multidisciplinary synthesis of the latest research in the field, Asthma's Impact on Society is an indispensable reference for pulmonologists, clinical immunologists and allergists, chest physicians, internists, pediatricians, health policy analysts, health economists, public health officials, pharmacoeconomists, and upper-level undergraduate, graduate, and medical school students in these disciplines.
Written by over 25 highly esteemed experts, Asthma's Impact on Society
Representing a multidisciplinary synthesis of the latest research in the field, Asthma's Impact on Society is an indispensable reference for pulmonologists, clinical immunologists and allergists, chest physicians, internists, pediatricians, health policy analysts, health economists, public health officials, pharmacoeconomists, and upper-level undergraduate, graduate, and medical school students in these disciplines.
